Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (121-130 of 425) with videos related to

Pageof 43
Sort By:
Cardiorenal Medicine|August 27, 2019
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of Hospitalization for New-Onset Kidney Disease: A Real-World Analysis of High-Risk Statin-Treated PatientsPeter P Toth, Sephy Philip, Michael Hull, et al.
Expert Review of Cardiovascular Therapy|August 1, 2008
Clinical characterization and molecular mechanisms of statin myopathyPeter P Toth, Charles R Harper, Terry A Jacobson
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 26, 2009
A guide to the management of blood pressure in the diabetic hypertensive patientNicolas W Shammas, Domenic A Sica, Peter P Toth
Frontiers in Pharmacology|May 28, 2026
Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectivesSeyed Saeed Tamehri Zadeh, Peter P Toth, Maciej Banach
Critical Pathways in Cardiology|February 14, 2015
Knowledge of PCSK9 and continued educational gaps: evaluating the impact of continuing medical educationAmy T Larkin, Colleen S Healy, Peter P Toth
European Heart Journal|July 14, 2023
Eliminating atherosclerotic cardiovascular disease residual riskMichael E Makover, Stanislaw Surma, Maciej Banach, et al.
Current Medical Research and Opinion|May 12, 2009
Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterolPeter P Toth, Victoria Zarotsky, Jane M Sullivan, et al.
International Journal of Clinical Practice|August 10, 2020
Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomesPantea Stoian Anca, Peter P Toth, Peter Kempler, et al.
Vascular Health and Risk Management|August 23, 2012
Ezetimibe therapy: mechanism of action and clinical updateBinh An P Phan, Thomas D Dayspring, Peter P Toth
European Heart Journal Open|May 24, 2024
Dyslipidaemia management in pregnant patients: a 2024 updateJoanna Lewek, Agata Bielecka-Dąbrowa, Peter P Toth, et al.
Pageof 43

Showing results (121-130 of 425) with videos related to

Sort By:
Pageof 43
Cardiorenal Medicine|August 27, 2019
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of Hospitalization for New-Onset Kidney Disease: A Real-World Analysis of High-Risk Statin-Treated PatientsPeter P Toth, Sephy Philip, Michael Hull, et al.
Expert Review of Cardiovascular Therapy|August 1, 2008
Clinical characterization and molecular mechanisms of statin myopathyPeter P Toth, Charles R Harper, Terry A Jacobson
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 26, 2009
A guide to the management of blood pressure in the diabetic hypertensive patientNicolas W Shammas, Domenic A Sica, Peter P Toth
Frontiers in Pharmacology|May 28, 2026
Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectivesSeyed Saeed Tamehri Zadeh, Peter P Toth, Maciej Banach
Critical Pathways in Cardiology|February 14, 2015
Knowledge of PCSK9 and continued educational gaps: evaluating the impact of continuing medical educationAmy T Larkin, Colleen S Healy, Peter P Toth
European Heart Journal|July 14, 2023
Eliminating atherosclerotic cardiovascular disease residual riskMichael E Makover, Stanislaw Surma, Maciej Banach, et al.
Current Medical Research and Opinion|May 12, 2009
Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterolPeter P Toth, Victoria Zarotsky, Jane M Sullivan, et al.
International Journal of Clinical Practice|August 10, 2020
Gender differences in the battle against COVID-19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomesPantea Stoian Anca, Peter P Toth, Peter Kempler, et al.
Vascular Health and Risk Management|August 23, 2012
Ezetimibe therapy: mechanism of action and clinical updateBinh An P Phan, Thomas D Dayspring, Peter P Toth
European Heart Journal Open|May 24, 2024
Dyslipidaemia management in pregnant patients: a 2024 updateJoanna Lewek, Agata Bielecka-Dąbrowa, Peter P Toth, et al.
Pageof 43